Eagle Pharmaceuticals (EGRX) Fails to deliver data

Key failure to deliver metrics for Eagle Pharmaceuticals :

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: ₹0 M
• Last 12 months FTD volume: ₹0.22 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eagle Pharmaceuticals (EGRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eagle Pharmaceuticals (EGRX) - since 2014

Eagle Pharmaceuticals (EGRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	₹54.31 M	₹94.31 M	🇺🇸 USA
GlaxoSmithKline GSK	₹72.01 M	₹0.40 B	🇬🇧 UK
Novartis NVS	₹18.77 M	₹0.12 B	🇨🇭 Switzerland
Teva Pharmaceutical Industries TEVA	₹1.84 M	₹36.3 M	🇮🇱 Israel
Amgen AMGN	₹5.75 M	₹0.21 B	🇺🇸 USA
Eli Lilly LLY	₹0.21 B	₹0.37 B	🇺🇸 USA
Bristol-Myers Squibb BMY	₹6.09 M	₹0.21 B	🇺🇸 USA